© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
Sathianathen, N. J., Philippou, Y. A., Kuntz, G. M., Konety, B. R., Lamb, A. D., & Dahm, P. (2017). Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer. Cochrane Database of Systematic Reviews, 2017(9), [CD012816]. https://doi.org/10.1002/14651858.CD012816